BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 12689404)

  • 1. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months.
    Cimentepe E; Unsal A; Saglam R
    J Endourol; 2003 Mar; 17(2):103-7. PubMed ID: 12689404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial.
    Hill B; Belville W; Bruskewitz R; Issa M; Perez-Marrero R; Roehrborn C; Terris M; Naslund M
    J Urol; 2004 Jun; 171(6 Pt 1):2336-40. PubMed ID: 15126816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
    Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
    BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia.
    Law YXT; Chen WJK; Shen L; Chua WJ
    Investig Clin Urol; 2019 Sep; 60(5):351-358. PubMed ID: 31501797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Thulium Laser Prostatectomy Versus Transurethral Resection of Prostate for Treatment of Benign Prostate Hyperplasia: A Meta-Analysis.
    Jiang H; Zhou Y
    Low Urin Tract Symptoms; 2016 Sep; 8(3):165-70. PubMed ID: 27619781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options.
    Schatzl G; Madersbacher S; Djavan B; Lang T; Marberger M
    Eur Urol; 2000 Jun; 37(6):695-701. PubMed ID: 10828670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral electrovaporization of the prostate: is it any better than standard transurethral prostatectomy? 5-year follow-up.
    Nuhoğlu B; Ayyildiz A; Fidan V; Ersoy E; Huri E; Germiyanoğu C
    J Endourol; 2005; 19(1):79-82. PubMed ID: 15735389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy.
    Kaya C; Ilktac A; Gokmen E; Ozturk M; Karaman IM
    BJU Int; 2007 Apr; 99(4):845-8. PubMed ID: 17378844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vapor resection: a good alternative to standard loop resection in the management of prostates >40 cc.
    Gupta NP; Doddamani D; Aron M; Hemal AK
    J Endourol; 2002 Dec; 16(10):767-71. PubMed ID: 12542882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive surgery in the management of benign prostatic hyperplasia.
    Berardinelli F; Hinh P; Wang R
    Minerva Urol Nefrol; 2009 Sep; 61(3):269-89. PubMed ID: 19773728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transurethral RollerLoop vapor resection of prostate for treatment of symptomatic benign prostatic hyperplasia: a 2-year follow-up study.
    Liu CK; Lee WK; Ko MC; Jeng HS; Chiang HS; Yu HJ
    Scand J Urol Nephrol; 2006; 40(5):409-15. PubMed ID: 17060088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis.
    Kaye JD; Smith AD; Badlani GH; Lee BR; Ost MC
    J Endourol; 2008 Apr; 22(4):713-8. PubMed ID: 18419216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.